-transparent.png){kind=logo}
The tissue concentration of doxorubicin (adriamycin; ADM) and its major metabolite (aglycone I) was examined in mice pretreated with alpha-tocopherol (VE) or coenzyme Q10 (CoQ). In VE-pretreated group, the concentrations of aglycone I of the liver (1, 3 and 5 h after the administration), kidney (1 and 3h) and heart (3h) were significantly higher than those in the saline group. The clinical application of VE or CoQ concomitant with anti-tumor drugs especially ADM, requires caution.
Related Publications
S Shinozawa, and
Y Gomita, and
Y Araki
June 1999,
Free radical biology & medicine,
S Shinozawa, and
Y Gomita, and
Y Araki
January 1979,
Cancer chemotherapy and pharmacology,
S Shinozawa, and
Y Gomita, and
Y Araki
May 1979,
Research communications in chemical pathology and pharmacology,
S Shinozawa, and
Y Gomita, and
Y Araki
March 2009,
Toxicology and applied pharmacology,
S Shinozawa, and
Y Gomita, and
Y Araki
October 1996,
Bratislavske lekarske listy,
S Shinozawa, and
Y Gomita, and
Y Araki
February 1960,
The Journal of biological chemistry,
S Shinozawa, and
Y Gomita, and
Y Araki
August 1980,
Research communications in chemical pathology and pharmacology,
S Shinozawa, and
Y Gomita, and
Y Araki
January 1997,
Molecular aspects of medicine,
S Shinozawa, and
Y Gomita, and
Y Araki
December 1991,
Annals of medicine,
S Shinozawa, and
Y Gomita, and
Y Araki
March 2005,
Free radical biology & medicine,
